Clinical Trials Browser

Stomach Neoplasms × Observation × Clear all

Stomach Neoplasms, Helicobacter Infections

NCT07400354 2026-02-10

The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota

Recruiting

300 enrolled

Gastrointestinal

Stomach Neoplasms

NCT05179824 2025-05-06

Tempus Priority Study: A Pan-tumor Observational Study

Active not recruiting

1,000 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmSarcomaThoracic

Bile Duct Neoplasms, Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT06706466 2024-11-26

Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy.

Completed

410 enrolled

Gastrointestinal

Stomach Neoplasms

NCT06493448 2024-07-10

Prospective Observational Cohort Study

Not yet recruiting

1,326 enrolled

Gastrointestinal

Stomach Neoplasms

NCT06313567 2024-07-08

Metronomic Capecitabine in Stage III Gastric Cancer

Phase 3 Recruiting

722 enrolled

Gastrointestinal

Stomach Neoplasms

NCT05468138 2022-08-26

PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery

Phase 2 Unknown

141 enrolled

Gastrointestinal

Stomach Neoplasms

NCT04439812 2020-06-19

Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer

Completed

267 enrolled

Gastrointestinal

Margins of Excision, Recurrence, Stomach Neoplasms

NCT03314649 2019-05-08

Peritoneal Lavage for Early Detecting Gene Mutation of Peritoneal Metastasis of Gastric Cancer

Completed

200 enrolled

Gastrointestinal

Stomach Neoplasms

NCT03701373 2018-10-10

Maintenance Treatment With S-1 in Gastric Cancer Patients

Phase 2 Unknown

200 enrolled

Gastrointestinal

Stomach Neoplasms

NCT00767234 2016-07-11

Permission to Collect Blood Over Time for Research

Terminated

104 enrolled

GastrointestinalSarcoma

Anus Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Gastrointestinal Stromal Tumors

Clinical Trials

An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori

The Efficacy of PD-1 Monoclonal Antibody Combined With Chemotherapy in Metastatic Gastric Cancer Based on Gut Microbiota

Tempus Priority Study: A Pan-tumor Observational Study

Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy.

Prospective Observational Cohort Study

Metronomic Capecitabine in Stage III Gastric Cancer

PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery

Influence of Positive Margins on Tumour Recurrence and Overall Survival After Gastrectomy for Gastric Cancer

Peritoneal Lavage for Early Detecting Gene Mutation of Peritoneal Metastasis of Gastric Cancer

Maintenance Treatment With S-1 in Gastric Cancer Patients

Permission to Collect Blood Over Time for Research